← Back to Clinical Trials
Recruiting NCT03835273

NCT03835273 Oesophagectomy and Chest Wall and Respiratory Function

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT03835273
Status Recruiting
Phase
Sponsor Imperial College London
Condition Esophageal Cancer
Study Type OBSERVATIONAL
Enrollment 100 participants
Start Date 2019-05-29
Primary Completion 2025-08-31

Trial Parameters

Condition Esophageal Cancer
Sponsor Imperial College London
Study Type OBSERVATIONAL
Phase N/A
Enrollment 100
Sex ALL
Min Age 18 Years
Max Age 90 Years
Start Date 2019-05-29
Completion 2025-08-31
Interventions
3D motion capture systemIncentive spirometryQuestionnaires

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Open surgery for esophageal cancer commonly involves large incisions in the chest, associated with a high rate of pulmonary complications (30-50%). Minimally invasive approach through keyhole surgery has been shown to reduce pulmonary infections by 20%. Enhanced recovery programmes are evidence-based protocols, developed to achieve early recovery after surgery with early mobilisation and chest physiotherapy and have been shown to reduce pulmonary complication rates as well. The investigators intend to objectively measure chest wall movement using 3D motion capture system as well as a wearable measurement system to monitor chest wall movement.

Eligibility Criteria

Inclusion Criteria: * Exposure group: 1. Patients treated more than a year ago with oesophagectomy for oesophageal cancer, by an open approach. 2. Patients able to understand and retain the information provided, thereby being able to give informed consent for inclusion in this study. * Control group: 1. Healthy volunteers with no underlying respiratory disease and no history of upper gastrointestinal surgery. 2. Individuals able to understand and retain the information provided, thereby being able to give informed consent for inclusion in this study. Exclusion Criteria: * Any participant who lacks capacity or is unable to provide informed consent. * Any participant younger than 18 or older than 90 years of age. * Any patient with evidence of cancer recurrence or on-going postoperative complication at more than one year following surgery for oesophageal cancer. * Any pregnant participant. * unable to or excluded from performing spirometry or respiratory muscle strength testing (non-inva

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology